Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06587321

Remote Assessment of Signs and Symptoms in Palliative Care

Digital health interventions, including remote monitoring of patients, have been identified as a possible way to address current problems within the health service, including insufficient numbers of staff, and an increasing number of patients requiring services.

The aim of this study is to assess the feasibility of using remote monitoring for patients who are receiving palliative care and to see whether remote monitoring can improve care and outcomes for patients and their families.

Participants in this study will complete regular (daily, weekly, monthly) questionnaires online about how they are feeling. They will also be given equipment to measure their vital signs every day. The clinical team will have access to the results and be able to respond to any new problems as they arise. Patients and their carers will then complete a questionnaire at one month to assess satisfaction with the use of remote monitoring.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Our Lady's Hospice & Care Services

Dublin, D6W RY72, Ireland

Location status: Recruiting

Location contact

Jenny Power

CONTACT

[email protected]

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Primary diagnosis of advanced cancer or another life-limiting condition
  • Estimated prognosis greater than 3 months
  • Referred for community-based specialist palliative care
  • Living in own home (or home of family carer)
  • Living with a family carer

Exclusion criteria

  • Estimated prognosis less than 3 months or more than 12 months
  • Cognitive impairment - unable to provide consent / complete assessments
  • Non-English speaker
  • Living in care home / nursing home / hospice / community hospital
  • Not living with a family carer

Treatment and study plan

Primary outcomes

  1. Completion rates of assessments

    Time frame: At the end of 1 month

    Number of assessments completed over the study time-frame

Secondary outcomes

  1. Recruitment rate

    Time frame: 6 months

    The number of patients approached to take part in the study who then entered the study

  2. Retention rate

    Time frame: 6 months

    The number of patients who entered and then completed the study

  3. Acceptability

    Time frame: 1 month

    A patient / carer acceptability questionnaire completed at 1 month into study period

  4. Use of community palliative care resources

    Time frame: 6 months

    Number of phone calls / visits / interventions participants receive

  5. Use of GP / hospital resources

    Time frame: 6 months

    The number of unplanned GP visits / hospital attendances over the study period

Study contacts

Contact information is provided by the study sponsor or research team.

Gemma O'Keeffe

CONTACT

[email protected]

01 406 8700 ext. 6235

Sponsors and collaborators

Lead sponsor

Our Lady's Hospice and Care Services

Other

Registry information

Official study title

The ReASSure-PC Study: A Feasibility Study of Remote Assessment of Signs and Symptoms in Palliative Care

Acronym: ReASSure-PC

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Sep 19, 2024
Registry last updated
Jun 27, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.